Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9603 posts found.

Takeda headquarters

Takeda buys Nycomed for $13.6bn

May 19, 2011 Manufacturing and Production, Research and Development, Sales and Marketing Nycomed, Takeda

Takeda has acquired Swiss specialist pharma firm Nycomed, boosting its presence in emerging markets. The deal comes in at 9.6 …
News
Shire UK

Shire makes $750m regenerative medicines acquisition

May 18, 2011 Manufacturing and Production, Research and Development, Sales and Marketing Shire, regenerative medicine

Shire’s ambitions to build a regenerative medicine business will soon be realised following its $750 million acquisition of Advanced BioHealing. …
News

Mark Dean-Netscher joins Penn Pharma

May 18, 2011 Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development

Penn Pharma has appointed Mark Dean-Netscher as its new chief operating officer. He has more than 20 years experience in …
Appointment

Sanofi strikes Crohn’s deal with Glenmark

May 16, 2011 Research and Development Crohn’s disease, Glenmark, Sanofi

Sanofi has signed a deal with Indian drug maker Glenmark Pharmaceuticals to develop a new treatment for Crohn’s Disease. The …
News
ABPI's London offices

ABPI and BIA move in together

May 16, 2011 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BIA

The UK’s pharma industry association the ABPI and its biotech equivalent the BIA are jointly relocating to new London offices. …
News

It’s time we redesigned the clinical trial

May 16, 2011 Research and Development clinical trials, randomised controlled trials

Who can remember a time when the pathway from laboratory bench to marketed product didn’t include clinical trial phases I …
Feature

Takeda denies $12bn Nycomed takeover reports

May 13, 2011 Research and Development, Sales and Marketing Nycomed, Takeda

Japan’s biggest pharma firm Takeda has denied reports it is negotiating a billion dollar deal to acquire Swiss speciality firm …
News
European Parliament

EMA under fire from European Parliament

May 13, 2011 Medical Communications, Research and Development, Sales and Marketing EMA, European Parliament, MEPs

The EMA has been hit by a barrage of criticism from the European Parliament over conflicts of interest and the …
News
GlaxoSmithKline

GSK and AZ collaborate on translational research centre

May 12, 2011 Research and Development AstraZeneca, GlaxoSmithKline, The University of Manchester, academic research, translational research

The University of Manchester has teamed up with GSK and AstraZeneca to create the Manchester Collaborative Centre for Inflammation Research …
News

Government wrong to push for Avastin in eye disease, says charity

May 12, 2011 Research and Development, Sales and Marketing Lucentis, RNIB, avastin, wet AMD

The UK government’s pursuit of Avastin for use in ophthalmology is bad for patients, says the Royal National Institute of …
News

AZ signs targeted colon cancer drug collaboration

May 11, 2011 Research and Development AstraZeneca, colorectal cancer, personalised medicine

AstraZeneca has entered a partnership which intends to speed up the development of targeted treatments for colorectal cancer, a disease …
News

Drug regulators protect profits over patients, new study finds

May 11, 2011 Research and Development Bad Science, Vioxx, regulatory affairs

Medicine regulators are protecting drug company profits over the welfare of patients by withholding trial data. That’s the verdict of …
News

Verdict on AMT’s gene therapy expected soon

May 11, 2011 Research and Development, Sales and Marketing AMT, Amsterdam Molecular Therapeutics, gene therapy, genes

Amsterdam Molecular Therapeutics says it will shortly receive the regulatory verdict on its gene therapy Glybera. Glybera (alipogene tiparvovec) is …
News

Service Insight: Clinical trials – managing route to market

May 11, 2011 Research and Development Service Insight, Talking Point, research and development

SERVICE INSIGHT Clinical trials are notoriously difficult to manage and often fraught with problems, as they can involve many clinical …
Feature

Pfizer drops early-stage asthma candidate

May 11, 2011 Research and Development Pfizer, Rigel, asthma

Pfizer has returned the rights to a phase I asthma candidate to Rigel Pharmaceuticals. San Francisco-based Rigel says Pfizer is …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026